Literature DB >> 8882999

Respiratory muscle perfusion and energetics during exercise.

J A Dempsey1, C A Harms, D M Ainsworth.   

Abstract

The oxygen cost of breathing and blood flow requirements of the respiratory muscles during exercise are discussed along with the implications for limitation of locomotor muscle and exercise performance. Findings show that the oxygen cost of the hyperpnea achieved during very heavy exercise may approach 15% or more of VO2max under conditions that require extraordinary levels of ventilatory work. These conditions include those in the highly trained endurance athlete (at VE > 150 l.min-1), the older athlete at VE of 110-120 l.min-1), and athletic cursorial mammals at VO2max--all of whom experience significant expiratory flow limitation and sometimes even complete ventilatory limitation during heavy or maximum exercise. Rates of blood flow to the respiratory muscles under these peak exercise conditions may equal or exceed those to the limb locomotor muscles. The hypothesis is advanced that excessive requirements of ventilatory work (and therefore VO2 and blood flow) during heavy exercise may cause reflex vasoconstriction of locomotor muscles resulting in curtailment of endurance exercise performance.

Entities:  

Mesh:

Year:  1996        PMID: 8882999     DOI: 10.1097/00005768-199609000-00007

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  10 in total

1.  Cardiac vagal tone, exercise performance and the effect of respiratory training.

Authors:  H Hepburn; J Fletcher; T H Rosengarten; J H Coote
Journal:  Eur J Appl Physiol       Date:  2005-05-20       Impact factor: 3.078

2.  Isocapnic hyperpnea training improves performance in competitive male runners.

Authors:  John J Leddy; Atcharaporn Limprasertkul; Snehal Patel; Frank Modlich; Cathy Buyea; David R Pendergast; Claes E G Lundgren
Journal:  Eur J Appl Physiol       Date:  2007-01-23       Impact factor: 3.078

3.  Canada's contribution to respiratory physiology and pathophysiology.

Authors:  Peter T Macklem
Journal:  Can Respir J       Date:  2007-10       Impact factor: 2.409

4.  Difference in the metabolic cost of postural actions during iso- and antidirectional coupled oscillations of the upper limbs in the horizontal plane.

Authors:  Roberto Esposti; Fabio Esposito; Emiliano Cé; Fausto Baldissera
Journal:  Eur J Appl Physiol       Date:  2009-09-16       Impact factor: 3.078

5.  Respiratory muscle training improves swimming endurance in divers.

Authors:  Juli A Wylegala; David R Pendergast; Luc E Gosselin; Dan E Warkander; Claes E G Lundgren
Journal:  Eur J Appl Physiol       Date:  2006-12-13       Impact factor: 3.078

6.  Anaerobic work capacity in cycling: the effect of computational method.

Authors:  Erik P Andersson; Philipp Bachl; Anna Schmuttermair; Craig A Staunton; Thomas L Stöggl
Journal:  Eur J Appl Physiol       Date:  2022-09-17       Impact factor: 3.346

7.  Effects of overground locomotor training on the ventilatory response to volitional treadmill walking in individuals with incomplete spinal cord injury: a pilot study.

Authors:  Gino S Panza; Andrew A Guccione; Lisa M Chin; Jared M Gollie; Jeffery E Herrick; John P Collins
Journal:  Spinal Cord Ser Cases       Date:  2017-04-13

8.  The role of anticipatory postural adjustments in interlimb coordination of coupled arm movements in the parasagittal plane: III. difference in the energy cost of postural actions during cyclic flexion-extension arm movements, ISO- and ANTI-directionally coupled.

Authors:  Roberto Esposti; Eloisa Limonta; Fabio Esposito; Fausto G Baldissera
Journal:  Exp Brain Res       Date:  2013-10-06       Impact factor: 1.972

9.  Mechanisms of physical activity limitation in chronic lung diseases.

Authors:  Ioannis Vogiatzis; George Zakynthinos; Vasileios Andrianopoulos
Journal:  Pulm Med       Date:  2012-12-12

Review 10.  The individual response to training and competition at altitude.

Authors:  Robert F Chapman
Journal:  Br J Sports Med       Date:  2013-12       Impact factor: 13.800

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.